George M. Abraham, MD, MPH, MACP, FIDSA, FRCP (Lon.)
Chief of Medicine
Dr. George M. Abraham is Chief of Medicine at Saint Vincent Hospital, Worcester, Massachusetts, a Professor of Medicine at the University of Massachusetts Medical School, and Adjunct Professor at the Massachusetts College of Pharmacy and Health Sciences (MCPHS). He is board certified in Internal Medicine and Infectious Disease.
He is the Emeritus President of the American College of Physicians (ACP), which is the largest internal medicine specialty organization in the world, having served from 2021-22. Prior to that, he served as Governor of the Massachusetts Chapter, Chair of the Board of Governors (ACP) and as a member of the Board of Regents (ACP).
Dr. Abraham is Chair-Elect of the Federation of State Medical Boards (FSMB), the organization that oversees licensing of over 1.1 million physicians in the US, and also the Federation Credentials Verification Service (FCVS). Prior to that, he was the Chair of the Board of Registration (Licensing) in Medicine, Massachusetts.
Dr. Abraham serves as a member of the Board of Directors of the American Board of Internal Medicine (ABIM) and prior to that, has served as the Chair of the Infectious Disease Board of the ABIM.
In other roles in leadership, he has served as a Trustee of the Massachusetts Medical Society (owner of the New England Journal of Medicine), as President of the Worcester District Medical Society, as the Chief Medical Officer of the Central Massachusetts Independent Physician Association and Chair of the Board of Directors of the Health Foundation of Central Massachusetts.
He has received several awards including the AOA Volunteer Faculty Award and the Outstanding Primary Care Educator Award of UMass Medical School; the Leadership Award of the MA chapter of the ACP; and the Phi Lambda Sigma honorary Membership, MCPHS, Worcester, Massachusetts, Saint Vincent Hospital Physician of the Year 2015, among others. Most recently, he is the recipient of the John H. Clarke Leadership Award awarded by the Federation of State Medical Boards.
He is an invited speaker both locally, nationally and internationally, and as President, he has championed the cause of DEI and written extensively about the same. Consequently, he has been invited to, and has spoken both nationally and internationally on DEI, and continues to do so. His particular passions is for inclusivity, and has chosen to focus on the international medical graduate community that forms 25 percent of the US physician workforce and over 30% of the ACP’s membership.
His research interests include hepatitis C and B disease, travel medicine and infection control, as well as medication safety and systems improvement. He has authored over 125 publications, abstracts and book chapters, and is an invited speaker at national and international meetings.
Dr. Abraham earned his medical degrees from the Christian Medical College, Ludhiana, India, completed his residency and chief residency at Saint Vincent Hospital, and received his master’s degree in public health from the Johns Hopkins Bloomberg School of Public Health.
Selected Bibliography (recent):
- Qaseem A, Yost J, Miller M, Andrews RE, Jokela JA, Abraham GM, Forciea MA, Humphrey LL for the Scientific Medical Policy Committee of the American College of Physicians. Outpatient Treatment of Confirmed COVID-19: Living, Rapid Practice Points From the American College of Physicians (Version 1) DOI: https://doi.org/10.7326/M22-2249
- Qaseem A, Yost J, Abraham GM, Andrews RE, Jokela JA, Miller MC, Humphrey LL, Obley AJ, Akl, EA for the Scientific Medical Policy Committee of the American College of Physicians. Outpatient Treatment of Confirmed COVID-19: Living, Rapid Practice Points From the American College of Physicians (Version 2) DOI: 7326/M23-1636
- Patel R, Dani SS, Khadke, S, Kumar A, Ahmad J, Saji, AM, Shah J, Mehta N, Wener K, McQuillen DP, Abraham GM, Faust J, Maley J, Patel S, Mullington J, Wachter RM, Mosenthal A, Sax PE, Ganatra S. Nirmatrelvir-Ritonavir for Acute COVID-19 in Patients with Cardiovascular Disease and Postacute Sequelae of SARS-CoV-2 Infection. JACC: Advances, Vol.3,No.6, 2024, June 2024:100961 http://creativecommons.org/licenses/by/4.0/
- Shanmugavel Geetha H, Gogtay M, Prabhu S, Sekar A, Singh Y, Abraham GM. Martin S. Can inflammatory markers be used as an early predictor for mechanical ventilation in COVID-19 patients with Stages IIIb-V chronic kidney disease? Open Forum Infectious Diseases, Volume 9, Issue Supplement_2, December 2022 https://doi.org/10.1093/ofid/ofac492.323
- Kumar MS, Kumar SA, Mishra R, Rai M, George S, Abraham GM, Seetharaman K. Self-Sustainability with Therapeutic Phlebotomy, a Solution to the National Blood Crisis?. Blood. 2023 Nov 28; 142:5051. American Society of Hematology (ASH) Nov 2023. https://doi.org/10.1182/blood-2023-187612.